June 12, 2025 — Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that targets four gut hormones instead of the usual one to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Objective To develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of ...

New Classification to Describe Clinical Presentation in Aortic Stenosis: Stable, Progressive, and Acute Valve Syndrome Philippe Généreux, Brian R. Lindman, Philippe Pibarot PDF Full Text Abstract Save ...

Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...

Atherosclerotic cardiovascular disease (ASCVD) was identified based on participants’ history of coronary heart disease, angina, heart attack, or stroke, consistent with clinical guidelines for ASCVD ...

Both Novo Nordisk and Lilly are responding to the competition to their obesity products from compounding pharmacies, which have been able to offer discounted versions of semaglutide and ...

We collected demographic data, preoperative co-morbidities, laboratory results, and perioperative data, including age, gender, Barthel Index (BI) score (especially evaluating for frailty), ASA ...